Advertisement
Screener

Genprex, Inc. (GNPX) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

2.8 / 5 stars · 68/120 Roast Me

Genprex, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

Genprex, Inc. (GNPX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.11 million as of 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-30

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.11M.
  • 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.30M.
  • 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $306.91K.
  • 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $94.24K.
Period endDeferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
2025-12-31$1.11M
10-K · filed 2026-03-30
2024-12-31$1.30M
10-K · filed 2026-03-30
2023-12-31$306.91K
10-K · filed 2025-04-01
2022-12-31$94.24K
10-K · filed 2024-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02